Oracle, Salesforce dip among Thursday's market cap stock movers

Thursday's market has seen notable movements across a spectrum of stocks, with some of the largest companies experiencing declines, while others in the large-cap space are on the rise. Mega-cap stocks like Oracle Corp (NYSE:ORCL ) and Salesforce Com (NYSE:CRM ) have seen a downturn, while large-cap players such as MicroStrategy Inc (NASDAQ:MSTR ) are bucking the trend with impressive gains. Here's a look at some of the most significant stock movers of the day, from mega-caps to small caps.

Mega-Cap Movers (Market Cap $200B+):Oracle Corp (ORCL): -4.03%Salesforce Com (CRM): -3.84%Avago Technologies (NASDAQ:AVGO ): -3.08%Servicenow Inc (NYSE:NOW ): -2.68%Adobe Sys Inc (NASDAQ:ADBE ): -2.21%

Large-Cap Stock Movers (Market Cap $10B-$200B):Dell Inc (NYSE:DELL ): -12.25%Hewlett-pack (NYSE:HPQ ): HP stock downgraded to Hold by HSBC on weak 1QFY25 outlook and rising commodity costs; -11.36%MicroStrategy Inc (MSTR): +9.94%Autodesk Inc (NASDAQ:ADSK ): -8.59%Nutanix Inc (NASDAQ:NTNX ): Nutanix to Present at Upcoming Investor Conference; -7.81%BeiGene (NASDAQ:BGNE ): +7.31%Reinvent Technology Partners Y (AUR): +7.27%Li Auto Inc (NASDAQ:LI ): American Lithium Reports Results of Annual General and Special Meeting; +6.78%IBIT NASDAQ (IBIT): +6.44%FBTC NYSE (FBTC): +6.37%

Mid-Cap Stock Movers (Market Cap $2B-$10B):SVF Investment 3 (SYM): -35.87%Iris Energy (IREN): +29.71%Arrowhead Research Corp (NASDAQ:ARWR ): +24.23%Urban outfitters (NASDAQ:URBN ): +18.31%Hut 8 Mining PK (HUT): +16.5%HCM Acquisition (MRNO): +16.17%Good Works Acquisition (CIFR): +14.56%MSTU (MSTU): +13.93%

Small-Cap Stock Movers (Market Cap $300M-$2B):Advanced Photonix Inc (API): +33.97%ETHU (ETHU): +18.79%Golden Bull (BTBT): +18.45%Fate Therap (NASDAQ:FATE ): +18.28%Kingsoft Cloud Holdings Ltd (KC): +17.42%Immunome Inc (NASDAQ:IMNM ): +16.83%Wowo Ltd (MFH): -16.32%Semler Scientifc (NASDAQ:SMLR ): +16.06%Applied Therapeutics Inc (NASDAQ:APLT ): FDA declines approval for Applied Therapeutics' Galactosemia drug; -16.06%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Source: Investing.com